Annual Total Assets
$83.94 M
+$33.04 M+64.90%
31 December 2023
Summary:
SAB Biotherapeutics annual total assets is currently $83.94 million, with the most recent change of +$33.04 million (+64.90%) on 31 December 2023. During the last 3 years, it has risen by +$27.40 million (+48.47%). SABS annual total assets is now at all-time high.SABS Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Assets
$53.80 M
-$8.09 M-13.08%
30 September 2024
Summary:
SAB Biotherapeutics quarterly total assets is currently $53.80 million, with the most recent change of -$8.09 million (-13.08%) on 30 September 2024. Over the past year, it has increased by +$25.46 million (+89.85%). SABS quarterly total assets is now -53.99% below its all-time high of $116.93 million, reached on 30 September 2021.SABS Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SABS Total Assets Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +64.9% | +89.8% |
3 y3 years | +48.5% | -54.0% |
5 y5 years | - | - |
SABS Total Assets High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | +64.9% | -54.0% | +89.8% |
5 y | 5 years | at high | +366.3% | -54.0% | +89.8% |
alltime | all time | at high | +366.3% | -54.0% | +89.8% |
SAB Biotherapeutics Total Assets History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $53.80 M(-13.1%) |
June 2024 | - | $61.89 M(-13.3%) |
Mar 2024 | - | $71.37 M(-15.0%) |
Dec 2023 | $83.94 M(+64.9%) | $83.94 M(+196.2%) |
Sept 2023 | - | $28.34 M(-20.1%) |
June 2023 | - | $35.44 M(-16.9%) |
Mar 2023 | - | $42.67 M(-16.2%) |
Dec 2022 | $50.90 M | $50.90 M(-3.1%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2022 | - | $52.51 M(-11.2%) |
June 2022 | - | $59.15 M(-12.3%) |
Mar 2022 | - | $67.47 M(-16.8%) |
Dec 2021 | $81.14 M(+43.5%) | $81.14 M(-30.6%) |
Sept 2021 | - | $116.93 M(+115.7%) |
June 2021 | - | $54.21 M(-4.1%) |
Dec 2020 | $56.54 M(+214.0%) | $56.54 M |
Dec 2019 | $18.00 M | - |
FAQ
- What is SAB Biotherapeutics annual total assets?
- What is the all time high annual total assets for SAB Biotherapeutics?
- What is SAB Biotherapeutics annual total assets year-on-year change?
- What is SAB Biotherapeutics quarterly total assets?
- What is the all time high quarterly total assets for SAB Biotherapeutics?
- What is SAB Biotherapeutics quarterly total assets year-on-year change?
What is SAB Biotherapeutics annual total assets?
The current annual total assets of SABS is $83.94 M
What is the all time high annual total assets for SAB Biotherapeutics?
SAB Biotherapeutics all-time high annual total assets is $83.94 M
What is SAB Biotherapeutics annual total assets year-on-year change?
Over the past year, SABS annual total assets has changed by +$33.04 M (+64.90%)
What is SAB Biotherapeutics quarterly total assets?
The current quarterly total assets of SABS is $53.80 M
What is the all time high quarterly total assets for SAB Biotherapeutics?
SAB Biotherapeutics all-time high quarterly total assets is $116.93 M
What is SAB Biotherapeutics quarterly total assets year-on-year change?
Over the past year, SABS quarterly total assets has changed by +$25.46 M (+89.85%)